Comparison of a Standardized Procedure with Current Laboratory Practices for the Detection of Lupus Anticoagulant in France

Summary

A multicenter study involving 13 laboratories was designed to compare a common procedure for screening lupus anticoagulants (LA) to the different practices currently in use in these laboratories. The common procedure combined 3 phospholipid- dependent assays, including mixing studies and a phospholipid neutralizing test. Due to the heterogeneity of LA expression, an abnormal result in at least one of the tests was sufficient to classify a sample as positive for LA. Consecutive samples referred for LA diagnosis were evaluated in parallel by each participant and the data found using the common procedure were analyzed independently according to mutually agreed cut-offs and criteria for sample classification. Within a period of 3 months, 535 samples were included, of which 147 were judged LA positive, 29 undetermined and 359 negative by the respective laboratories using their current practice. When using the common procedure, 149 plasmas were said to be positive, 38 undetermined and 348 negative. Absolute concordance occurred for 81% of the specimen population and absolute discordance (positive versus negative) for 7%. The level of agreement between the common procedure and the current practices, assessed by kappa indexes, indicated noticeable variations in the rates of detection from laboratory to laboratory. Among the different tests used in the common procedure, regular APTT was the least sensitive (about 50% detection) but none of the other tests alone recognized more than 73% of specimens from the LA positive population. This yield increased to about 90% with any combination of 2 sensitive tests. The common procedure should not be considered as a methodological gold standard but as an acceptable basis for the collaborative works required for the improvement and standardization of laboratory practices for screening LA.

• References

• 1 Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. Thrromb Haemostas 1991; 65: 320-322
• 2 Triplett DA, Brandt J. Laboratory identification of the lupus anticoagulant. Br J Haematol 1989; 73: 139-142
• 3 Hemostasis Committee on the “Société Française de Biologie Clinique”. Laboratory heterogeneity of the lupus anticoagulant: a multicentre study using different clotting assays on a panel of 78 samples. Thromb Res 1992; 66: 349-364
• 4 Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemostas 1987; 57: 144-147
• 5 Triplett DA, Hannah D, Barna L. Hexagonal (II) phase phospholipid neutralization of lupus anticoagulants: a specific and sensitive confirmatory procedure. Thromb Haemostas 1991; 65: 1255 (Abstr)
• 6 Illescas FF, Leclerc J, Rosenthall L, Wolfson C, Rush C, Herba MJ, Arzoumanian A. Interobserver variability in the interpretation of contrast venography, technetium-99m red blood cell venography and impedance plethysmography for deep vein thrombosis. J Can Assoc Radiol 1990; 41: 264-269
• 7 Triplett DA. Laboratory diagnosis of lupus anticoagulants. Sem Thromb Hemost 1990; 16: 182-192
• 8 Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1). Thromb Haemostas 1990; 64: 478-484
• 9 The Lupus Anticoagulant Working Part Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom. J Clin Pathol 1990; 43: 73-75
• 10 Brandt JT, Triplett DA, Rock WA, Bovill EG, Arkin CF. Effect of lupus anticoagulants on the activated partial thromboplastin time. Arch Pathol Lab Med 1991; 115: 109-114
• 11 Barna LK, Triplett DA. A report on the first international workshop for lupus anticoagulant identification. Clin Exp Rheum 1991; 9: 557-567
• 12 Triplett DA, Brandt JT, Maas RL. The laboratory heterogeneity of lupus anticoagulants. Arch Pathol Lab Med 1985; 109: 946-951
• 13 Brandt JT. Assays for phospholipid-dependent formation of thrombin and Xa: a potential method for quantifying lupus anticoagulant activity. Thromb Haemostas 1991; 66: 453-458
• 14 Brandt JT, Triplett DA, Musgrave K, Orr C. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants. Arch Pathol Lab Med 1987; 111: 120-124
• 15 Clyne LP, White PF. Time dependency of lupuslike anticoagulants. Arch Intern Med 1988; 148: 1060-1063
• 16 Lo SCL, Oldmeadow MJ, Howard MA, Firkin BG. Comparison of laboratory tests used for indentification of the lupus anticoagulant. Am J Haematol 1989; 30: 213-220
• 17 Liu HW, Wong KL, Lin CK, Wong WS, Tse PWT, Chan GTC. The reappraisal of dilute tissue thromboplastin inhibition test in the diagnosis of lupus anticoagulant. Br J Haematol 1989; 72: 229-234
• 18 Johns AS, Ockelford PA, Chamley L, Pattison NS, McKay EJ, Corkill M, Hart H. Comparison of tests for the lupus anticoagulant and phospholipid antibodies in systemic lupus erythematosis. Thromb Haemostas 1989; 62: 380 (Abstr)